Phase two of the Royal Commission of Inquiry will look further into the government decisions over vaccine use and lockdowns ...

The author says the action creates mistrust of the committee’s vaccine recommendations and further increases patients’ and ...

Expert team, headed by Jayadeva Institute of Cardiovascular Sciences & Research head, has instead said that vaccine has shown ...

The chief of Jayadeva Hospital has stated that reports submitted to the government show no correlation between COVID-19 ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.

COVID is still with us, and there will be other pandemics. It’s critical that we don’t forget the lessons we’ve learned.” ...

Following the dismissal of members from the CDC's vaccine advisory committee, a federal health expert predicts the changes on ...

We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy.

Moderna stock is indeed in the doldrums today, but this offers the opportunity to buy at a reasonable price, and, 10 years ...

A Centers for Disease Control and Prevention official said Tuesday she was resigning from her role overseeing updates to the agency’s COVID-19 vaccine recommendations, following an order by Health and ...

The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: ...